References
- LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
- VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
- HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med2004350262645265315215480
- MishimaMHiraiTItohHComplexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary diseaseProc Natl Acad Sci U S A199996168829883410430855
- MatsuokaSKuriharaYYagihashiKNakajimaYMorphological progression of emphysema on thin-section CT: analysis of longitudinal change in the number and size of low-attenuation clustersJ Comput Assist Tomogr200630466967416845301
- MatsuokaSKuriharaYYagihashiKQuantitative thin-section CT analysis of the enlargement and coalescence of low-attenuation clusters in patients with emphysemaRespiration200774213614117008789
- NakanoYMuroSSakaiHComputed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung functionAm J Respir Crit Care Med20001623 Pt 11102110810988137
- HasegawaMNasuharaYOnoderaYAirflow limitation and airway dimensions in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2006173121309131516556695
- XieXDijkstraAEVonkJMOudkerkMVliegenthartRGroenHJChronic respiratory symptoms associated with airway wall thickening measured by thin-slice low-dose CTAJR Am J Roentgenol20142034W383W39025247967
- PatelBDCoxsonHOPillaiSGAirway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2008178550050518565956
- KimVDaveyAComellasAPCOPDGene® InvestigatorsClinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPD Gene studyRespir Res2014155224766722
- MatsuokaSWashkoGRYamashiroTNational Emphysema Treatment Trial Research GroupPulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysemaAm J Respir Crit Care Med2010181321822519875683
- MatsuokaSWashkoGRDransfieldMTQuantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitationAcad Radiol2010171939919796970
- MatsuuraYKawataNYanagawaNQuantitative assessment of cross-sectional area of small pulmonary vessels in patients with COPD using inspiratory and expiratory MDCTEur J Radiol201382101804181023769190
- JonesPWAndersonJACalverleyPMTORCH investigatorsHealth status in the TORCH study of COPD: treatment efficacy and other determinants of changeRespir Res2011127121627828
- SoejimaKYamaguchiKKohdaELongitudinal follow-up study of smoking-induced lung density changes by high-resolution computed tomographyAm J Respir Crit Care Med20001614 Pt 11264127310764322
- TanabeNMuroSHiraiTImpact of exacerbations on emphysema progression in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2011183121653165921471102
- TanabeNMuroSOgumaTComputed tomography assessment of pharmacological lung volume reduction induced by bronchodilators in COPDCOPD20129440140822509949
- OharaTHiraiTSatoSLongitudinal study of airway dimensions in chronic obstructive pulmonary disease using computed tomographyRespirology200813337237818399859
- SaruyaSMatsuokaSYamashiroTQuantitative CT measurements of small pulmonary vessels in chronic obstructive pulmonary disease: do they change on follow-up scans?Clin Physiol Funct Imaging201636321121725393655
- American Thoracic Society European Respiratory Society Task ForceStandards for the Diagnosis and Management of Patients with COPD. Version 1.2New York, NYAmerican Thoracic Society2004 [updated September 8, 2005]. Available from: http://www.thoracic.org/go/copdAccessed August 1, 2016
- Committee of Pulmonary Physiology. The Japanese Respiratory SocietyGuidelines for pulmonary function tests: spirometry, flow-volume curve, diffusion capacity of the lung1st edTokyoMedical Review Co, Ltd2004 Nihon Kokyuki Gakkai Zasshi2004Suppl156 Japanese
- WashkoGRDransfieldMTEsteparRSAirway wall attenuation: a biomarker of airway disease in subjects with COPDJ Appl Physiol (1985)2009107118519119407254
- YamashiroTMatsuokaSEsteparRSQuantitative assessment of bronchial wall attenuation with thin-section CT: an indicator of airflow limitation in chronic obstructive pulmonary diseaseAJR Am J Roentgenol2010195236336920651191
- KiyokawaHMuroSOgumaTImpact of COPD exacerbations on osteoporosis assessed by chest CT scanCOPD20129323524222360380
- SukiBLutchenKRIngenitoEPOn the progressive nature of emphysema: roles of proteases, inflammation, and mechanical forcesAm J Respir Crit Care Med2003168551652112941655
- WinklerTSukiBEmergent structure-function relations in emphysema and asthmaCrit Rev Biomed Eng201139426328022011233
- VestboJEdwardsLDScanlonPDECLIPSE InvestigatorsChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med2011365131184119221991892
- BarnesPJCOPD: is there light at the end of the tunnel?Curr Opin Pharmacol20044326327215140418
- AndoKKuraishiHNagaokaTPotential role of CT metrics in chronic obstructive pulmonary disease with pulmonary hypertensionLung2015193691191826453478
- MatsuokaSYamashiroTMatsushitaSRelationship between quantitative CT of pulmonary small vessels and pulmonary perfusionAJR Am J Roentgenol2014202471972424660697
- HueperKVogel-ClaussenJParikhMAPulmonary microvascular blood flow in mild chronic obstructive pulmonary disease and emphysema. The MESA COPD StudyAm J Respir Crit Care Med2015192557058026067761
- HasegawaMMakitaHNasuharaYRelationship between improved airflow limitation and changes in airway calibre induced by inhaled anticholinergic agents in COPDThorax200964433233819074932
- YoshimuraKSuzukiYUtoTSatoJImokawaSSudaTMorphological changes in small pulmonary vessels are associated with severe acute exacerbation in chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2016111435144527418816
- SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
- HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
- Soler-CatalunaJJMartinez-GarciaMARoman SanchezPSalcedoENavarroMOchandoRSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
- BurgeSWedzichaJACOPD exacerbations: definitions and classificationsEur Respir J Suppl20034146s53s12795331
- GreenbergSBAllenMWilsonJAtmarRLRespiratory viral infections in adults with and without chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2000162116717310903237
- TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
- BarrRGBourbeauJCamargoCARamFSTiotropium for stable chronic obstructive pulmonary disease: a meta-analysisThorax2006611085486216844726
- RennardSIAndersonWZuWallackRUse of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116351087109211316640
- RossiAKristufekPLevineBEFormoterol in Chronic Obstructive Pulmonary Disease (FICOPD) II Study GroupComparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPDChest200212141058106911948033
- JonesPWWillitsLRBurgePSCalverleyPMInhaled Steroids in Obstructive Lung Disease in Europe study investigatorsDisease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbationsEur Respir J2003211687312570111
- PeinadoVIPizarroSBarberaJAPulmonary vascular involvement in COPDChest2008134480881418842913
- SuzukiTTadaYKawataNClinical, physiological, and radiological features of asthma-chronic obstructive pulmonary disease overlap syndromeInt J Chron Obstruct Pulmon Dis20151094795426028967
- BarnesPJMechanisms in COPD: differences from asthmaChest2000117Suppl 210S14S10673467
- ZaniniAChettaAImperatoriASSpanevelloAOlivieriDThe role of the bronchial microvasculature in the airway remodelling in asthma and COPDRespir Res20101113220920222
- KasaharaYTuderRMTaraseviciene-StewartLInhibition of VEGF receptors causes lung cell apoptosis and emphysemaJ Clin Invest2000106111311131911104784
- KasaharaYTuderRMCoolCDLynchDAFloresSCVoelkelNFEndothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysemaAm J Respir Crit Care Med20011633 Pt 173774411254533
- DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
- AnthonisenNRConnettJEKileyJPEffects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyJAMA199427219149715057966841
- GagnonPCasaburiRSaeyDCluster analysis in patients with GOLD 1 chronic obstructive pulmonary diseasePLoS One2015104e012362625906326
- DecramerMCelliBKestenSLystigTMehraSTashkinDPUPLIFT investigatorsEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet200937496961171117819716598